Melanotan II (MT-II)
Synthetic Melanocortin Peptide | Tanning & Sexual Function
Community Research
Join others researching Melanotan II — share findings, ask questions, and learn from real experiences
Melanotan II is a synthetic analog of alpha-melanocyte-stimulating hormone (α-MSH) that activates melanocortin receptors throughout the body. MC1R activation triggers melanin production for tanning, while MC4R affects sexual arousal and appetite control.
Binds to melanocortin receptors (MC1R for tanning, MC4R for sexual function and appetite) to stimulate melanin production, enhance libido, and suppress appetite through hypothalamic pathways.
Molecular Data
Research Indications
Stimulates natural melanin production for tanning without requiring UV exposure.
Increased melanin provides natural SPF protection against sun damage.
May help address certain pigmentation disorders.
Improves sexual desire in both men and women through MC4R activation.
80% response rate in psychogenic erectile dysfunction studies.
73% of women reported arousal within 24 hours in clinical trials.
MC4R activation in hypothalamus reduces appetite (15% caloric intake reduction in studies).
Enhanced fat oxidation through metabolic pathway activation.
Dosing Protocols
Subcutaneous injection is the standard and most effective route. Start with low doses to assess tolerance due to nausea risk.
| Goal | Dose | Frequency | Route |
|---|---|---|---|
| Initial loading phase | 0.25mg | 1x daily | SubQ |
| Tanning maintenance | 0.5-1mg | 2-3x weekly | SubQ |
| Sexual enhancement | 0.5-1mg | As needed | SubQ |
| Minimal side effects | 0.1-0.25mg | Every other day | SubQ |
| Photoprotection | 0.5mg | 2x weekly | SubQ |
Reconstitution Instructions
- Melanotan II lyophilized powder (typically 10mg vial)
- Bacteriostatic water (2mL for 5mg/mL concentration)
- Insulin syringes
- Alcohol swabs
- Aluminum foil (light protection)
- 1 Clean vial tops with alcohol swab, let dry
- 2 Draw 2mL bacteriostatic water for 10mg vial (creates 5mg/mL)
- 3 Inject water slowly down vial side to avoid foaming
- 4 Gently roll vial - do not shake vigorously
- 5 Solution should be clear to slightly yellow
- 6 Wrap vial in foil (MT-II is light sensitive)
- 7 Store in refrigerator
- 8 Draw dose with insulin syringe (typical: 0.05-0.2mL)
Protocol Variations
Multiple approaches exist - compare before choosing
Different sources recommend different protocols for this peptide. Review each approach and consider your goals, tolerance, and experience level before choosing.
Traditional Loading Protocol
TraditionalSource: Legacy Bodybuilding Forums
"Aggressive daily loading to build melanin quickly"
A decade-old protocol involving daily injections at higher doses for 1-2 weeks before maintenance. This approach is associated with more side effects including nausea and increased freckling/mole development. Dosing on non-tanning days can lead to uneven pigmentation.
Key Points
- Higher starting doses (250-500mcg)
- Daily dosing regardless of tanning
- 1-2 week loading period before UV exposure
- Higher risk of nausea, freckling, and new moles
- Can cause uneven tanning when UV begins
Dosing Schedule
Pre-Tan Only Protocol
AlternativeSource: More Plates More Dates
"ONLY dose on tanning days - loading phase is unnecessary"
NEVER administer on non-tanning days. Always tan within 1 hour of injection. Start extremely low (50-75mcg) and increase by 25mcg every 3 sessions. This dramatically reduces freckling, uneven pigmentation, and side effects. The traditional loading phase is considered counterproductive - it builds melanin in areas with high melanocyte activity (freckles, moles, genitals) rather than where UV protection is needed.
Key Points
- Start at only 50-75mcg (much lower)
- ONLY inject on days you tan - never otherwise
- Must tan within 1 hour of injection
- Increase dose by 25mcg every 3 sessions
- Also increase tan time by 1 min per 3 sessions
- Takes weeks/months to reach higher doses
- Minimal freckling and side effects
- More economical and sustainable long-term
Dosing Schedule
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
- Nausea (pre-treatment with antiemetics recommended)
- Facial flushing
- Temporary blood pressure elevation
- Fatigue
- Spontaneous erections
Stop Signs - Discontinue if:
- Severe persistent nausea or vomiting
- Chest pain or significant blood pressure elevation
- Mole changes (size, shape, color) - monitor closely
- Prolonged painful erections (priapism)
- Severe headaches or vision changes
- Allergic reactions (rash, swelling, breathing difficulty)
Contraindications
- History of melanoma or dysplastic nevi
- Pregnancy or breastfeeding
- Cardiovascular conditions
- Uncontrolled hypertension
Quality Checklist
Good Signs
- White to off-white lyophilized powder
- Clear to pale yellow solution when reconstituted
- Vacuum sealed vial with audible 'pop' when opening
Warning Signs
- Protect from light exposure - MT-II is photosensitive
- Wrap vials in foil for storage
Bad Signs
- Brown or dark powder indicates oxidation/impurities
- Cloudy solution after mixing indicates degradation/contamination
References
- Melanocortin Receptor Agonists, Penile Erection, and Sexual Motivation: Human Studies with Melanotan IIWessells H, Levine N, Hadley ME, Dorr RT, Hruby VJInternational Journal of Impotence Research (2000)
20 men with psychogenic/organic ED; 0.025mg/kg dose. Melanotan II induced penile erection in 17/20 men without sexual stimulation. Increased sexual desire in 68% vs 19% placebo (P<0.01).
- Increased Eumelanin Expression and Tanning Is Induced by a Superpotent Melanotropin [Nle4-D-Phe7]-alpha-MSH in HumansDorr RT, Lines R, Levine N, et al.Journal of Investigative Dermatology (2000)
Seven volunteers received 0.16mg/kg/day subcutaneous injections for 10 days. Mean 49% increase in forehead eumelanin and 98% increase in forearm eumelanin one week post-treatment.
- Evaluation of Melanotan-II, a Superpotent Cyclic Melanotropic Peptide in a Pilot Phase-I Clinical StudyDorr RT, Lines R, Levine N, Brooks C, et al.Life Sciences (1996)
Phase I study in 3 normal male volunteers. Daily subcutaneous injections for 2 weeks produced visible skin darkening in the face, upper body, and buttock after only 5 low doses.
Related Peptides
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.